• Sharebar

Anyone following this? Looks like a hostile takeover strategy case study. It covers staggered boards, proxy advisory firms, and poison pills. Really interesting. Is it gonna happen? If you were the adviser to Roche or Illumina, what would tell them?

Out of curiosity, how are hedgies and arbs playing this?


Comments (4)

  • TOB2020's picture

    GSK just started one with HGSI

  • In reply to DarkPool
    SECfinance's picture

    To unlock this content for free, please login / register below.

    Sign In with Facebook Sign In with Google

    Connecting helps us build a vibrant community. We'll never share your info without your permission. Sign up with email or if you are already a member, login here Bonus: Also get 6 free financial modeling lessons for free ($200+ value) when you register!